XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 34,716,600 $ (3,756,262)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and other amortization 386,440 393,667
Gain on change in fair value of warrant liability (400,663) (294,548)
Stock-based compensation 1,092,893 957,320
Write down of inventory, net 168,446 548,551
Deferred income taxes, net (1,761,279) (408,233)
Changes in assets and liabilities:    
Accounts receivable 28,724,892 (482,561)
Inventory (11,919,413) (9,956,076)
Prepaid expenses and other assets 1,514,150 (139,984)
Accounts payable, accrued expenses and other liabilities 914,139 9,095,055
Income tax payable (10,083,889) (871,298)
Deferred revenue 6,364,971 306,443
Net cash provided by/(used in) operating activities 49,717,287 (4,607,926)
Cash flows from investing activities:    
Capital expenditures 0 (24,424)
Cash used in investing activities 0 (24,424)
Cash flows from financing activities:    
Payment of employee tax obligations for common stock tendered (12,533) (173,918)
Repurchase of common stock (10,149,704) (20,264,547)
Payment of dividend (32,944,314) 0
Cash used in financing activities (43,106,551) (20,438,465)
Net increase/(decrease) in cash and cash equivalents 6,610,736 (25,070,815)
Cash and cash equivalents at the beginning of period 103,138,819 117,890,240
Cash and cash equivalents at end of period 109,749,555 92,819,425
Supplemental disclosure of non-cash financing activities:    
Conversion of warrant to common stock $ 6,120,778 $ 0